Tech On Drugs - Episode 4 - Dr. Emanuele de Rinaldis, Sanofi
![Tech On Drugs - Episode 4 - Dr. Emanuele de Rinaldis, Sanofi](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/b771c209998e979fec81cce487e673fc.jpg)
Sign up for free
Listen to this episode and many more. Enjoy the best podcasts on Spreaker!
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
What will the future of precision medicine look like 5-10 years down the line? And how will AI accelerate this future? I asked Dr. Emanuele de Rinaldis to answer this...
show moreI asked Dr. Emanuele de Rinaldis to answer this and many other questions.
Emanuele is VP, Global Head of Precision Medicine & Computational Biology at Sanofi R&D.
He believes that AI will help us define new taxonomies of diseases. We will identify different types of Asthma, different types of Fibrosis.
And AI will help us create a new textbook – not one driven by just clinical observations, but a textbook driven by genetics and gene expression, together with real world evidence.
This will take drug development and precision medicine to a level we have never seen before.
Information
Author | CytoReason |
Organization | Yoav Schumacher |
Website | - |
Tags |
-
|
Copyright 2024 - Spreaker Inc. an iHeartMedia Company